We are live on ! Find out more
ALXA

Alexza Pharmaceuticals Inc
ALXA

Delisted

ALXA was delisted on the 16th of June, 2016.

38 hedge funds and large institutions have $15.2M invested in Alexza Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,766% more call options, than puts

Call options by funds: $2.87M | Put options by funds: $154K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less funds holding

Funds holding: 40 → 38 (-2)

23% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 13

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

57% less capital inflows, than outflows

Capital inflows: $2.79M | Capital outflows: $6.51M

Holders
38
Holders Change
-2
Holders Change %
-5%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
10
Reduced
13
Closed
8
Calls
$2.87​M
Puts
$154​K
Net Calls
+$2.72​M
Net Calls Change
-⁠$2.6​M

ALXA Hedge Fund Activity: Q3 2014 in Review

38 of the 3,454 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q3 2014, worth a combined $15.2M — down 49% from $30M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ALXA and 5 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 10 added.

The largest buyer was Lansdowne Partners Austria, adding an estimated $1.02M. The largest seller was Federated Hermes, exiting entirely with an estimated $3.06M sold.

  • 38 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q3 2014, down from 40 in Q2 2014.
  • Funds reported $15.2M of Alexza Pharmaceuticals Inc stock for Q3 2014, down 49% quarter-over-quarter.
  • 5 funds opened new Alexza Pharmaceuticals Inc positions in Q3 2014 and 8 closed out, a net change of -3 holders.
  • The largest Alexza Pharmaceuticals Inc buyer in Q3 2014 was Lansdowne Partners Austria, an estimated $1.02M added.
  • The largest Alexza Pharmaceuticals Inc seller in Q3 2014 was Federated Hermes, an estimated $3.06M sold.

Based on aggregated 13F filings for Q3 2014.